Phase 2 Lung Cancer Trial, Not Yet Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have been diagnosed with Stage III or Stage IV non-small cell lung cancer (a type of lung cancer) that cannot be removed by surgery
- You are generally able to carry out some daily activities, though you may have some limitations due to your illness (confirm with trial site)
- Your cancer does not have certain specific genetic changes, or those genetic changes are not yet known
- You are planned to receive a chemotherapy combination (called platinum doublets), with or without immunotherapy medicines
- Your blood counts, liver, and kidney are working well enough to meet specific health thresholds (confirm with trial site for exact values)
Who may not be able to join:
- You have had an allergic reaction to a supplement called alpha lipoic acid in the past
- You are currently pregnant or breastfeeding
- You are taking iron supplements that may interact with alpha lipoic acid
- You are taking thyroid medications that may interact with alpha lipoic acid
- You have severe memory problems, a neurological condition such as dementia or Alzheimer's disease, or a severe mental health condition that would make it difficult to follow the study requirements
- You have uncontrolled heart disease, such as a recent heart attack or heart failure
- You have high blood pressure that cannot be controlled with medication
- You have cancer that has spread to your brain
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
1. Clinical Benefit Rate (CBR); 2. Tumor Response Rate (ORR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.